ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Astral shares fell nearly 6% to Rs 1,389 after the board approved demerging its chemicals business into a new entity, Astral Chemie. The demerger was approved via a Composite Scheme of Arrangement. Investors should evaluate the restructuring's impact on valuation and future growth.
Tap to vote and see what everyone thinks.
Summary by ByteBrief